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Abstract 
 Mouse F9 cells differentiate into primitive endoderm (PrE) when treated with 
retinoic acid (RA) and this is accompanied by the upregulation of Wnt6 and activation of 
the canonical WNT/β-catenin pathway. Previous studies have demonstrated the necessity 
of β-catenin-TCF/LEF transcription for primitive endoderm differentiation, however the 
Frizzled (FZD) receptor responsible for binding WNT6 and activating the canonical 
WNT pathway is not known. It was hypothesized that FZD7 is responsible for binding 
and transducing the WNT6 signal. Fzd7 mRNA is detected in undifferentiated and 
primitive endoderm cells, and its expression does not change significantly in response to 
RA. Moreover and contrary to my hypothesis, the knockdown of endogenous Fzd7 with 
siRNA does not attenuate differentiation. Other Fzd receptors are expressed in F9 cells 
and notably Fzd1, 4 and 8 are significantly upregulated by RA, and it is possible that one 
or more of these are serving to induce the WNT6 signal. That said, this study supports the 
notion that canonical WNT signaling activated through FZD receptors is necessary for 
PrE differentiation as the inhibitor Dickkopf-1 (Dkk1) is upregulated in response to RA, 
and expressing human DKK1 in undifferentiated F9 cells or treating cells with DKK1 
conditioned medium impedes the ability of RA to induce PrE. Together, this data 
indicates that FZD receptors are involved in WNT6 signal transduction in F9 cells and 
attenuating canonical WNT signaling using DKK1 blocks the ability of RA to induce 
PrE. 
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Chapter 1  
1 Introduction 
1.1 Early mouse development and epithelial-to-
mesenchymal  transitions 
 A fertilized mouse egg undergoes several cleavage events that partition the 
cellular components asymmetrically such that by the end of the 8-cell morula stage, the 
resulting cells are restricted to different developmental fates [1]. Cells of the morula give 
rise to two distinct lineages that contribute to the early blastocyst: the trophoblast and the 
inner cell mass (ICM) [2].  Signals received from the underlying ICM by the trophoblast 
cells trigger the proliferation and differentiation of the trophoblast into extraembryonic 
ectoderm, the primary role of which is to contribute to embryonic implantation and 
placental development. The ICM differentiates into the epiblast and extraembryonic 
endoderm, the former giving rise to the embryo proper and the latter to the primitive 
endoderm (PrE) [1, 2] (Fig. 1.2). 
 The PrE in turn differentiates into the parietal endoderm (PE) and visceral 
endoderm (VE), which give rise to the parietal and visceral yolk sacs, respectively [3]. 
These structures are not part of the embryo proper, but physically connect the embryo to 
the uterine wall to provide protection and nourishment during development [1]. The 
process that leads to the development of the PrE and subsequently PE from the ICM is 
considered to be the first of many epithelial-to-mesenchymal transition (EMT) events in 
the developing mouse embryo [4]. The changes in cell morphology and gene expression 
that characterize an EMT include a loss of E-cadherin expression, an increase in cell 
motility, and a change in cell polarity. EMTs are of significant importance in the 
developing embryo as without them the formation of important structures such as the 
neural crest would not occur [4]. EMTs also underlie the basis of metastatic cancer, thus 
studying them in these models provides insight into the mechanisms that control normal 
embryogenesis and development. 
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Figure 1.1 Mouse early embryonic development. The extraembryonic endoderm (ExE) 
consists of the primitive, parietal, and visceral endoderms. The primitive endoderm (PrE) 
segregates from the inner cell mass (ICM) at the blastocyst stage. PrE further 
differentiates into parietal and visceral endoderm, which give rise to the parietal and 
visceral yolk sacs, respectively. PrE cells that remain attached to the basement membrane 
of the ICM become visceral endoderm (VE) while other cells undergo an epithelial-to-
mesenchymal-transition to become parietal endoderm (PE).  The PE and VE lineages are 
highly important for proper development of the epiblast as together they are responsible 
for foetal-maternal nutrient/waste exchange prior to placentation. Adapted from Anne 
Grapin-Botton (2008). 
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1.2 F9 teratocarcinoma cells 
 The EMT that results in PE formation occurs at the time of embryonic 
implantation, approximately 4.5 days after fertilization in the mouse, and is therefore 
technically difficult to study in vivo. The use of certain in vitro models has allowed 
researchers to circumvent the issue of inaccessibility to the early mouse embryo and 
therefore allowed the study of the signalling events involved in the EMT associated with 
extraembryonic endoderm (ExE) formation [5]. One such in vitro model is the F9 cell 
line which was derived from an experimentally induced teratocarcinoma, generated by 
ectopic implantation of a six-day old embryo into the testes of a 129/J mouse. Under 
normal culture conditions, F9 cells undergo spontaneous differentiation at a very low 
frequency. However when treated with physiological concentrations (10
-7
 M) of the 
vitamin A derivative retinoic acid (RA), F9 cells undergo phenotypic changes that 
resemble formation of PrE [6]. The effect of RA is mediated by binding to RA receptors 
(RARs) and retinoid X receptors (RXRs), which form homo- or heterodimers that bind 
the RA response element (RARE) to regulate the transcription of target genes [7]. Many 
of these genes encode cytoskeletal proteins, which play an integral role during the 
morphogenesis that accompanies EMTs. 
 In response to RA, some F9 cells will remain in groups and adopt a polygonal 
morphology, while others move apart from each other forming large cytoplasmic 
processes and adopting a stellate appearance [8]. As F9 cells undergo this transformation, 
intermediate filament proteins assemble and can be identified with TROMA-1, a 
TROphectodermal Monoclonal Antibody. TROMA-1 binds endoA-positive cytokeratin 
intermediate filaments (cytokeratin-8) that are synthesized in TE cells, but not in those of 
the ICM cells [9]. The induction of F9 cells from the undifferentiated state into PrE is the 
first step of the EMT; however, it is not complete until the cells have differentiated 
further into PE. RA on its own is sufficient to induce cells to form PrE, but further 
signalling is necessary to induce cells to differentiate into PE. 
 The addition of RA to F9 cells causes wide scale changes in the expression profile 
of many hundreds of genes [10]. There is also an increase in the activation of the mitogen 
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activated protein kinase (MAPK) pathway, and its subsequent downregulation is 
necessary for the F9 cells to become PE and complete the EMT [11]. This 
downregulation is accomplished by the addition of dibutyryl cyclic adenosine 
monophosphate (db-cAMP). The elevation of intracellular cAMP activates Protein 
Kinase A (PKA), which negatively regulates the activity of the MAPK pathway, allowing 
the cells to complete the PrE to PE transition [11]. Another pathway that is activated in 
response to RA and central to my studies involves the canonical Wnt/β-catenin pathway 
[12, 13]. 
1.3 Canonical Wnt/β-catenin signalling pathway 
 WNTs are a family of secreted glycoproteins that elicit a multitude of cellular 
responses in embryos, neonates and adults. The effects of a WNT ligand binding to one 
of its seven transmembrane (7-TM) spanning Frizzled (FZD) receptors are pleiotropic 
and include stimulation of cell proliferation, cell motility and control of cell 
fate/differentiation [14]. Although in the fully developed individual, WNTs are important 
for normal tissue maintenance, abnormal WNT signalling promotes osteoarthritis as well 
as neurodegenerative diseases and cancer [15]. There are 19 known mammalian WNT 
proteins that have the potential to signal through one or more of three different WNT 
pathways: the canonical/β-catenin, and the non-canonical WNT/Ca2+ and planar cell 
polarity (PCP) pathways [14, 15]. WNT ligands activate the canonical pathway and alter 
cell fate/proliferation, whereas activation of either of the two non-canonical pathways 
tends to affect cell polarity, adhesion and motility through cytoskeletal reorganizations 
[16]. In the case of F9 cells, RA treatment leads to an up-regulation of Wnt6, which then 
activates the canonical Wnt/β-catenin pathway [12].  
 The canonical WNT/β-catenin pathway is the most well understood of the WNT 
pathways. In the absence of a WNT ligand, the intracellular levels of β-catenin are 
maintained at a low level through association with a protein complex known as the “β-
catenin destruction complex” that consists of the proteins AXIN, adenomatous polyposis 
coli (APC), glycogen synthase kinase 3 (GSK-3), and casein kinase 1 (CK1) [15]. The 
interaction of β-catenin with the destruction complex results in its initial and subsequent 
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phosphorylation by CK1 and GSK-3, respectively, and its eventual proteasome-mediated 
degradation. When WNT is present, however, it can bind to its serpentine FZD receptor 
at the cell surface along with the low density lipoprotein (LDL) receptor-related protein 
5/6 (LRP5/6) [15]. Binding leads to activation of the FZD receptor and recruitment of the 
scaffold proteins Dishevelled (DVL) and AXIN to the plasma membrane. The disruption 
of this destruction complex prevents the phosphorylation of β-catenin, allowing it to 
accumulate in the cytosol and translocate to the nucleus, where it interacts with the T-
cell-factor-lymphoid enhancer factor (TCF-LEF) family of transcription factors to 
activate transcription of WNT target genes [15]. Thus, the interaction of β-catenin with 
TCFs-LEFs converts them from transcriptional repressors to activators, which promotes 
the expression of genes that allow the induction of the PrE phenotype (Fig. 1.2). 
 
1.4 WNT-Frizzled signalling during development and in F9 
cell differentiation 
 As noted earlier, RA treatment of F9 cells leads to an up-regulation of Wnt6, 
which when translated activates the canonical WNT/β-catenin pathway. Research from 
our laboratory has shown that treatment of undifferentiated F9 cells with WNT6 
conditioned medium, or exogenous expression of Wnt6, is sufficient for PrE induction 
[12]. As canonical WNT signalling is mediated through FZD and its co-receptor LRP5/6, 
then one or more FZD receptor types, present on the surface of undifferentiated F9 cells, 
likely bind to WNT6 and transduce the signal. Incidentally, F9 cells require the activation 
of more than one WNT signalling pathway to complete differentiation into PE: canonical 
WNT/β-catenin signalling for differentiation of F9 cells into PrE, and the non-
canonical/PCP pathway to mediate proper migration and orientation of PE cells required 
for PE differentiation and the completion of EMT [13] [17].Therefore, a receptor that has 
the potential to activate both of these WNT signalling pathways would serve as an 
attractive candidate for inducing differentiation of F9 cells into ExE. Among the ten 
members of the FZD receptor family, FZD7 has been shown to mediate both canonical  
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Figure 1.2 The canonical Wnt/β-Catenin signalling pathway.  (A) In the absence of a 
WNT ligand, cytoplasmic β-catenin is phosphorylated by a complex of proteins known as 
the “destruction complex” composed of axin, adenomatous polyposis coli (APC), casein 
kinase 1 (CK1), and glycogen synthase kinase 3 (GSK3). CK1 and GSK3 phosphorylate 
the amino terminal of β-catenin, resulting in the ubiquitination of β-catenin and its 
subsequent degradation. Canonical WNT target genes are thereby repressed by 
transcription factors of the T cell factor/lymphoid enhancer factor (TCF/LEF) family. (B) 
When WNT is present and bound to FZD and its low-density lipoprotein receptor-related 
protein 5/6 (LRP5/6) co-receptor, the Disheveled (DVL) protein is recruited to the cell 
membrane resulting in LRP5/6 phosphorylation and disassembly of the destruction 
complex. β-catenin accumulates in the cytosol and subsequently translocates to the 
nucleus, where it complexes with TCF/LEF and causes target gene activation. Adapted 
from MacDonald, Tamai and He (2009). Reprinted with permission from Elsevier. 
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and non-canonical WNT signals in several different cell types [18]. One potential 
candidate involved in the differentiation of ExE is encoded by Fzd7. It is the most 
predominantly expressed Fzd receptor in triple negative breast cancer cells and its 
overexpression is associated with increased metastatic potential and cell proliferation 
through activation of the canonical WNT pathway [10]. In colorectal cancer, FZD7 is 
reported to be involved in both motility and invasiveness through activation of the non-
canonical/PCP pathway and increased cell survival through canonical WNT/β-catenin 
signalling [19]. Particularly of interest is the role of FZD7 in Xenopus (Xfz7) endoderm 
progenitor cells, where WNT binding leads to activation of either the canonical/β-catenin 
or non-canonical/PCP pathway and the pathway activated is dependent on the dose of 
WNT that the cells received, which was modulated by the soluble inhibitor of Wnt 
signaling Secreted Frizzled-Related Protein 5 (SFRP5). This latter example thus 
demonstrates that not only can a single FZD receptor activate more than one WNT 
pathway in the same cell type, but also that the WNT dosage can specify activation of 
one pathway over another [18]. In addition to regulating proper foregut development, 
Xfz7 is also required for the formation of the neural crest, which is dependent on an 
EMT, and accompanied by the activation of the canonical/β-catenin pathway [20]. As 
EMTs are fundamental processes that control morphogenesis in multicellular organisms, 
many of the mechanisms and signal transduction pathways involved in their regulation 
are well-conserved [21]. FZD7 has been shown to activate WNT signalling in several 
developmental EMTs and also in cancer cell models where EMTs mediate progression of 
the malignant phenotype, thus pointing to its role in controlling these processes [19]. 
Thus, FZD7 is capable of interacting with multiple WNT ligands and activating multiple 
pathways, but whether or not it serves as a receptor for WNT6 during F9 cell 
differentiation remains to be determined. A link between WNT6 and FZD7 has been 
proposed in the developing chick, where WNT6 signalling through the canonical β-
catenin pathway is responsible for maintaining the epithelial structure of somites [22]. It 
is interesting to note from this study that WNT6 might maintain the expression of FZD7 
as blocking the WNT6 signal emanating from ectoderm overlaying the somites results in 
a loss of FZD7 expression in the somites. Although this may not be a general 
phenomenon and may only be specific to the developing chick, it does provide evidence 
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linking WNT6 and FZD7 in a developmental model. Preliminary data from our lab would 
also indicate that FZD7 is sufficient to cause differentiation, as evident from the results 
from the transient over-expression of Fzd7 in undifferentiated F9 cells, showing that PrE 
is induced and is accompanied by phosphorylation and hence inactivation of GSK-3β, a 
negative regulator of canonical Wnt/β-catenin pathway activation (Benjamin Cadesky, 
unpublished data). 
 Sequence homology between Fzd7 and the other Fzd receptors may account 
for functional redundancy in various developmental processes regulated by WNT 
signalling. Homology analysis of Fzd receptors indicates that they share approximately 
20-40% sequence identity, which is higher within certain clusters [23]. Specifically, Fzd7 
is grouped within the same cluster as Fzd1 and Fzd2 and shares 75% sequence identity 
with these receptors [23]. Liu et al. demonstrated that ectopic expression of  rat Fzd1 or 
Fzd2 β-adrenergic chimeras in mouse F9 cells is sufficient to induce PrE. These results, 
however, may not be physiologically relevant as both Fzd1 and Fzd2 constructs used in 
these studies generated chimeric receptors, the result of fusing the sequence encoding the 
extracellular and transmembrane domains of the β-adrenergic receptor with the 
intracellular components of rFzd1/2 [24, 25]. Finally, there is a link noted between the 
up-regulation of WNT6 with FZD1 and FZD2 in human breast cancer cells, but whether 
or not this occurs in the context of F9 cell differentiation remains to be determined [26]. 
 
1.5 Frizzled receptor structure and WNT-Frizzled selectivity 
 Frizzled proteins were first identified as receptors for WNT ligands in D. 
melanogaster [27]. Frizzled receptors display many similarities to classical G-protein 
coupled receptors (GPCRs), yet are distinct enough to be grouped into their own class 
within this superfamily [28]. It was initially postulated that FZD receptors, despite 
demonstrating the 7-TM spanning hydrophobic domains characteristic of GPCRs, were 
not coupled to G-proteins and used other means to transduce signals downstream. G-
proteins were introduced into the mechanistic explanation of FZD signalling when it was 
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shown that the WNT-Ca
2+
 signalling pathway in zebrafish embryos could be inhibited by 
the addition of pertussis toxin [29]. Historically, the WNT/β-catenin and WNT-PCP 
pathways were considered to be independent of heterotrimeric G-proteins. However, a 
growing body of evidence indicates that G-proteins, interacting with DVL, a key player 
in canonical and non-canonical WNT signalling, play a more central role in the 
transduction of WNT signals [29]. 
 Structurally, FZD receptors consist of seven hydrophobic alpha helical segments, 
which comprise the transmembrane domains, three extracellular and three intracellular 
loops, an extracellular N-terminus, and an intracellular C-terminal tail [30]. Within the C-
terminus of FZD receptors is a completely conserved KTXXXW (X= any amino acid) 
motif, which is responsible for the interaction of FZD with the PDZ domain of DVL [31]. 
This interaction recruits AXIN to the cell membrane, which effectively inactivates the -
catenin destruction complex. The N-terminus of FZD contains a signal sequence peptide 
that ensures proper trafficking and membrane insertion of the receptor into the 
membrane, as well as a cysteine-rich domain (CRD). The CRD contains ten highly 
conserved cysteine residues that are thought to be the main WNT ligand binding domain 
[30]. Dimerization of the FZD receptors through disulfide bond formation within the 
CRDs occurs, and in some instances this dimerization alone is sufficient to activate 
WNT/β-catenin signalling [32].  
  The mechanisms by which signalling specificity is imparted between the nineteen 
WNT ligands and ten FZD receptors are poorly understood. The combinatorial and 
temporal expression of the different FZD receptors, co-receptors, WNT ligands and 
extracellular antagonists such as secreted frizzled-related proteins (SFRPs), are likely to 
be responsible for activation of different signalling pathways by the same FZD receptor. 
A “WNT switch” mechanism has been proposed to explain the activation of multiple 
WNT pathways by the same FZD receptor, with lower concentrations of WNT ligand 
activating the WNT-Ca
2+
 pathway and higher concentrations responsible for -catenin 
signalling [33]. However it is not known if such a model is responsible for PrE formation 
in F9 cells. 
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1.6 Secreted antagonists of WNT signalling 
 There are several secreted proteins that modulate WNT signaling during 
development by preventing the interaction of WNT ligands with their FZD receptors 
and/or co-receptors [34]. These extracellular antagonists of WNT signalling are divided 
into two functional classes: the secreted Frizzled-related protein (sFRP) class and the 
Dickkopf (DKK) class. Members of the sFRP class include the sFRP family, WNT 
inhibitory factor 1 (WIF-1), and Cerberus. This class of inhibitors antagonizes WNT 
signalling by directly binding to WNT and preventing WNT from interacting with its 
receptors [34]. The DKK family inhibits canonical WNT/β-catenin signalling by binding 
to the LRP5/6 co-receptor and prevents formation of a WNT-FZD-LRP5/6 ternary 
complex. Thus, in theory, the sFRP class will inhibit both canonical and non-canonical 
WNT signalling, whereas the DKK class specifically inhibits canonical WNT/β-catenin 
signalling [34]. The Dkk family encodes secreted proteins and consists of four members, 
Dkk 1-4 [35]. DKK1 was the founding member of the family and it was discovered to 
block WNT signalling which is required for head induction during Xenopus development 
[36]. Since its initial discovery, DKK1 has been shown to inhibit canonical WNT/β-
catenin signalling in many cell types and vertebrate species [35]. A negative feedback 
loop involving DKK1 was discovered in WNT signalling when four TCF/LEF binding 
elements were identified within the mDkk1 promoter [35]. Indeed, the expression of Dkk1 
is upregulated in many diseases/cancers in which WNT signalling is constitutively active 
[37, 38]. As aberrant activation of the WNT pathway is the hallmark of many cancers, 
initiation of the expression of negative feedback regulators that control the duration and 
intensity of the WNT signal is an important mechanism to maintain WNT signalling 
homeostasis in cellular processes that utilize this pathway [39]. 
 There is evidence that F9 cells express inhibitors of WNT signalling that may be 
used “turn off” the WNT pathway once cells have differentiated. In a microarray 
profiling study using F9 cells, Gudas et al. identified two RA-target genes Dab2 and 
sFRP-5, both of which encode inhibitors of WNT signalling [40]. Additionally, in F9 
cells expressing a chimeric rFzd1-β-adrenergic receptor, stimulation of the chimeric 
receptor with β-agonist to activate FZD signalling induces PrE differentiation and this is 
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accompanied by an upregulation of sFRP-1 expression [41]. As well, F9 cells induced to 
differentiate into VE are not responsive to WNT ligands, suggesting a blockade in WNT 
signalling accompanies differentiation [42]. Taken together, these results may indicate 
the presence of a negative feedback loop involving both secreted and intraceullar 
antagonists of the WNT pathway that regulate WNT signalling during F9 cell 
differentiation. 
 
1.7 Rationale, objective and hypothesis 
 The primary goal of my research is to address the role of the FZD7 receptor in the 
process of primitive endoderm formation. Previous work from our laboratory has shown 
that transient overexpression of Wnt6 or Fzd7, as well as treatment of undifferentiated F9 
cells with WNT6 conditioned media, is sufficient to induce PrE. Thus, increasing WNT6 
or FZD7 levels on their own has the potential to activate a signalling cascade that allows 
naïve cells to adopt a new fate. Further research, however, is needed to determine if 
WNT6 can only induce differentiation in the presence of the FZD7 receptor. Based on the 
information above, I hypothesize that FZD7 is the receptor that binds to WNT6 and 
transduces its signal during RA-induced differentiation of F9 cells. If this is true, then 
Fzd7 mRNA and protein should be present in undifferentiated cells, awaiting the WNT6 
ligand that is seen following RA treatment. Another possibility is that other Fzd 
transcripts are present in undifferentiated F9 cells, and these encode receptors that act in a 
functionally redundant manner to FZD7. To test my hypothesis I first used qRT-PCR to 
catalogue the expression of the different Fzd receptors in undifferentiated and RA-
induced F9 cells, and then conducted knockdown experiments of Fzd7 mRNA and 
treated cells with RA to determine the effect on differentiation. If my hypothesis is 
correct then there will be no PrE differentiation in the absence of Fzd7. If on the other 
hand PrE markers appear in cells depleted of Fzd7, the qRT-PCR data will provide 
evidence as to the FZD receptor(s) that may be responsible for transducing the WNT6 
required for differentiation. The secondary goal of my research is to address the role of 
the secreted canonical WNT signalling antagonist DKK1, and whether it is involved in a 
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negative feedback loop regulating WNT signalling during F9 cell differentiation. To 
address this, the expression of Dkk1 was examined in F9 cells treated with RA or 
expressing Wnt6 using qRT-PCR. Additionally, F9 cells overexpressing human DKK1 or 
treated with DKK1 conditioned medium were induced with RA to examine the effect of 
ectopic DKK1 on RA-induced differentiation. As other pathways have been shown to 
crosstalk with the canonical WNT/β-catenin pathway during RA-induced differentiation 
[43], these experiments will determine the effect of inhibiting the canonical WNT 
pathway at the level of the receptor and co-receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
15 
 
 
 
2 Materials and Methods 
2.1 Cell culture, reverse transfection, and chemical 
treatments 
Mouse F9 teratocarcinoma cells (ATCC) were cultured in Dulbecco’s Modified 
Eagle medium (DMEM) (Gibco) supplemented with 1% penicillin-streptomycin (P/S) 
(Gibco) and 10% fetal bovine serum (FBS) (Gibco) and incubated at 37 °C and 5% CO2.  
Cells were cultured in 35 mm plates for transfection or 60 mm plates (Nunc 
Thermoscientific or Sarstedt) for protein and/or RNA isolation. Cells were transfected 
with empty vector, pcDNA3.1-Fzd7, pcDNA3.1-Wnt6, pcDNA3.1-MYC-DKK1, pBARL 
and pRL-TK constructs using Lipofectamine 2000 (Life Technologies) according to 
manufacturer’s recommendations. Briefly, 10 uL of Lipofectamine 2000 were combined 
with a total of 4 µg of plasmid DNA in Opti-MEM reduced serum medium (Life 
Technologies) and incubated for 20 min at RT. Fzd7 was subcloned into pcDNA3.1 
(Invitrogen) by Benajmin Cadesky. pRL-TK was provided by Dr. Rodney Dekoter 
(University of Western Ontario). pBARL was provided by Dr. S. Angers (University of 
Toronto).  pcDNA3.1-MYC-DKK1 was provided by Dr. Yonghe Li (Southern Research 
Institute, Birmingham, Alabama, USA). 
 For Fzd7 knockdown, three 27-mer antisense RNA sequences (Origene) were 
pooled together at 10 nM each. Approximately 2.5 x 10
5 
cells were added to 2 mL 
DMEM with serum and antibiotics and seeded directly into 35 mm dishes containing the 
Opti-MEM transfection mix. Medium was replaced after 6 h and approximately 1 x 10
5
 
cells were passaged into 60 mm dishes after 24 h and selected for antibiotic resistance 
with 1.75 mg/mL G418 sulfate (Sigma). Cells transfected with pcDNA3.1-MYC-DKK1or 
treated with MYC-DKK1 conditioned medium were treated with DMSO or 5 x 10
-8
 M 
RA for 4 days. For all other experiments, cells were treated with DMSO or 10
-7 
M RA for 
3 or 4 days. 
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2.2 Reverse-transcription PCR and quantitative reverse-
transcription PCR 
 Total RNA was isolated using the RNeasy Mini Kit (Qiagen) and used as a 
template for first-strand cDNA synthesis, using the High Capacity cDNA Reverse 
Transcription kit (Applied Biosystems) with 1 µg RNA. RNA was isolated following 
treatment of F9 cells with DMSO, RA (1, 2, 3, and 4 days post-treatment) or RA and 
dibutyrl-cyclic Adenosine Mono Phosphate (db-cAMP). For RT-PCR and qRT-PCR with 
Fzd primers, an on-column DNase digestion was performed on all RNA samples using 
the RNase-Free DNase kit (Qiagen) according to manufacturer’s protocol. Purity and 
concentration of RNA was analyzed using the NanoDrop2000C Spectrophotometer 
(Thermo Scientific).  PCR reactions were analyzed on 1% agarose gels containing 
RedSafe Nucleic Acid Stain (iNtRON Biotechnology) and amplicons were visualized 
using a FluorChem 8900 Gel Doc System (Alpha Innotech). All reactions were 
performed using the following thermo-cycling conditions for 35-40 cycles: 94 °C for 30 
s, the primer-specific annealing temperature for 30 s and 72 °C extension for 30 s. All 
amplicons were sequenced (Robarts Research Institute, Western University) and aligned 
to annotated sequences using the NCBI Basic Local Alignment Search Tool (BLAST) to 
confirm their identity. Primers sequences and annealing temperatures are listed in 
Appendix 1. 
 For qRT-PCR analysis, total RNA was isolated and reverse-transcribed into first-
strand cDNA as described above. For Fzd expression analysis, qRT-PCR was performed 
using the Rotor-Gene 3000 (Corbett Research) and Power SYBR Green Master Mix 
(Applied Biosystems) according to manufacturer’s protocol. For all other qRT-PCR 
reactions, the CFX Connect Real-Time PCR Detection System (Bio-Rad) was used with 
the SensiFAST SYBR No-ROX Kit (Bioline) according to manufacturer’s protocol. Each 
qRT-PCR reaction contained 10 µL of Power SYBR Green Master Mix or SensiFAST 
SYBR, 500 nM of each primer described above, and 1 uL of cDNA template. 
Amplification plots were analyzed using Rotor-Gene software or CFX Manager 
Software. Gene expression was quantified using the comparative cycle threshold (Ct) 
method and displayed as gene expression relative to the L14 (2
-ΔCt
) or as fold-change (2
-
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ΔΔCt
) relative to DMSO or empty vector control (Appendix 2, 4 and 5). L14 encodes the 
constitutively expressed 60S ribosomal protein L14 
 
2.3  Immunoblot Analysis 
 Protein lysates were prepared in radioimmunoprecipitation assay buffer (RIPA) 
containing 150mM sodium chloride, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 
50mM Tris-HCl and 1x Halt Protease inhibitor cocktail (Thermo Scientific). Protein 
concentrations were quantified using the DC (Detergent Compatible) protein assay (Bio-
Rad) and Modulus II Microplate Multimode Reader (Turner Biosystems). Approximately 
20 µg of protein were separated on 10% denaturing polyacrylamide gels for 2.5 h at 100 
V. Following electrophoresis, the proteins were electrophoretically transferred to 
polyvinylidene fluoride (PVDF) membranes (Pall Corporation) overnight at 4 °C and 20 
V in Tris-glycine transfer buffer containing 20% methanol. The membranes were blocked 
in Tris-buffered saline containing 0.1% Tween 20 (TBS-T) and 5% skim milk for 1 h at 
room temperature. Membranes were probed overnight at 4 °C with the following primary 
antibodies diluted in 5% bovine serum albumin (BSA) containing TBS-T: TROMA-1 
(1:5; 55kDa, Developmental Studies Hybridoma Bank), β-Actin (1:5000; 47kDa, Santa 
Cruz) and c-Myc (9E10) (1:50, approximately 39 kDa for MYC-DKK1 detection, Santa 
Cruz). Membranes were washed in TBS-T (three washes for five minutes each) and then 
probed with either HRP-conjugated goat anti-rat or anti-mouse secondary antibody(s) in 
5% skim milk in TBS-T for 2 h at room temperature. Following three additional five 
minute washes with TBS-T, signals were detected using the Supersignal West Pico 
Chemiluminescent Detection Kit (Pierce), then captured with Molecular Imager Gel Doc 
XR System (Bio-Rad) and imaged with Quantity One Software. Densitometry analysis 
was performed using ImageJ software. 
 
2.4 TCF/LEF reporter assay 
 Cells transfected with pBARL(β-Catenin-activated reporter luciferase) and then 
treated with DMSO or 10
-7 
M RA, or co-transfected with pBARL and pcDNA3.1-EV 
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(empty vector) or pcDNA3.1-Fzd7 in equal amounts, were collected 48 h post-treatment 
or post-transfection. Cells were also co-transfected with pRL-TK (Renilla luciferase) to 
normalize luciferase levels. Lysates were collected by gently shaking cells in 1 X Passive 
Lysis Buffer (PLB, Promega) for 15 min at room temperature. Luciferase activity was 
quantified using the Dual Luciferase Assay Reporter System (Promega) and the Modulus 
II Multimode Microplate Reader (Turner Biosystems). Briefly, 100 µL of Luciferase 
Assay Reagent was added to 75 µL of PLB lysate in a 96-well plate and firefly luciferase 
activity was quantified. 100 µL of Stop & Glo Reagent was added to each well and 
Renilla luciferase activity was then quantified. Firefly luciferase values were normalized 
to Renilla luciferase values. 
 
2.5 MYC-DKK1 conditioned medium 
 HEK-293 cells were grown to 90% confluence in 60 mm culture dishes and 
maintained in DMEM with 10% FBS and 1% P/S. Cells were transfected using 10 µL 
Lipofectamine 2000 with 4 µg pcDNA3.1-EV (empty vector) or pcDNA3.1-MYC-DKK1. 
Medium was replaced with complete DMEM after 6 hours and replaced again with 
serum-free medium containing 1% P/S after 24 h. The medium was collected after 48 h 
and centrifuged at 10,000 x g for 10 min at 4 °C to pellet cellular debris. The supernatant 
was then filter sterilized using 0.2 µm Acrodisc Syringe Filters (Pall Corporation) and 
concentrated using Amicon Ultra-4 Centrifugal Filter Units (10,000 nominal molecular 
weight limit-EMD Millipore) according to manufacturer’s instructions. Approximately 
1.2x10
4 
F9 cells were seeded in 12-well plates and co-treated with 5x10
-8 
M RA and 10 
µL of media concentrate from pcDNA3.1-EV or pcDNA3.1-MYC-DKK1 transfected cells. 
Cells were supplemented with 10 µL of concentrated medium every day for a total of 4 
days. For immunoblot analysis of concentrated conditioned medium, 5, 10 or 15 µL of 
medium from pcDNA3.1-EV or pcDNA3.1-MYC-DKK1 transfected cells were resolved 
by electrophoresis on 10% denaturing polyacrylamide gels, transferred to PVDF 
membranes and probed using the 9E10 antibody (Santa Cruz). 
 
19 
 
 
 
2.6 Statistical analysis 
 Densitometric analyses of immunoblots, qRT-PCR data, and Luciferase assay 
data were compiled from three independent biological replicates performed on separate 
occasions. Comparisons of data between the control and treated, or transfected groups 
were performed using a one-way ANOVA and Tukey’s honest significant difference 
(HSD) post-hoc test or a Student’s t-Test (SPSS Statistics for Windows Version 19.0, 
IBM Corp. Released 2010, Armonk, NY). One-way ANOVA followed by Tukey’s HSD 
test was used for statistical analysis of Luciferase assay data, Dkk1 and Dab2 qRT-PCR 
data, and densitometry data of TROMA-1 immunoblots from Fzd7 knockdown 
experiments. Student’s t-Test was used for statistical analysis of all other data. P-values 
were one-sided and considered statistically significant at the 0.05 level. Statistical data 
are presented as the mean ± S.E. 
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Chapter 2  
3 Results 
3.1 Frizzled7 expression 
 F9 teratocarcinoma cells differentiate into primitive endoderm when exposed to 
retinoic acid (RA) and to parietal endoderm when exposed sequentially to RA and 
dibutyryl cyclic adenosine monophosphate (db-cAMP). RA-induced differentiation is 
accompanied by an increase in Wnt6 expression, and WNT6 by itself induces 
differentiation [12]. Although a receptor for WNT6 in F9 cells has not been identified, 
FZD7 is a candidate and while there is a link between it and WNT6 in developing chick 
somites [22], more importantly its overexpression in F9 cells has been reported to induce 
primitive endoderm (Benjamin Cadesky, unpublished). RT-PCR was used to address if 
Fzd7 is expressed in F9 cells. Total RNA was collected from F9 cells and those treated 
with either RA for one to four days, or with RA and db-cAMP, and then reverse-
transcribed into first-strand cDNA for PCR. Results show the presence of an amplicon in 
all treatments, including the DMSO-treated controls (Fig. 3.1A). Amplicons were 
sequenced and all were found to be identical to the Fzd7 sequence appearing in the NCBI 
Nucleotide database. 
 The presence of a Fzd7 amplicon regardless of treatment prompted the need to 
use qRT-PCR to detect subtle changes in Fzd7 expression. Total RNA was collected from 
undifferentiated F9 cells and cells treated with RA for 3 days, and then reverse-
transcribed into cDNA for qRT-PCR with Fzd7-specific primers. Results showed that 
there was no significant change in Fzd7 mRNA abundance due to RA treatment (Fig. 
3.2B). To corroborate these results and to ensure that RA had induced differentiation, 
end-point PCR was used with Gata6-specific primers. That a Gata6 amplicon was only 
present in RA-treated cells indicated that RA had successfully induced the cells to form 
PrE (Fig 3.2C). To extend these studies, the expression of other members of the Fzd 
family was examined to determine if they were present in F9 cells and if so, whether their 
expression changed during RA-induced differentiation. 
21 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Fzd7 is expressed in undifferentiated and differentiated F9 cells and its 
expression is unaffected by RA exposure. (A) F9 cells were treated with either DMSO 
(control), RA for one to four days, or with RA and db-cAMP for four days (with db-
cAMP treatment after 48 h of RA exposure) and total RNA was collected, reverse-
transcribed into cDNA and used as a template for RT-PCR with primers designed to 
Fzd7. A Fzd7 amplicon was amplified from first strand cDNA derived from all 
treatments. The presence of the positive control, L14 amplicon, indicated that cDNAs 
were present in all treatments. (B) qRT-PCR analysis of Fzd7 in cells treated with RA 
(10
-7
M) for 3 days shows that Fzd7 expression in RA-treated cells is not significantly 
different from expression in undifferentiated (DMSO-treated) F9 cells. (C) Agarose gel 
showing the presence of a Gata6 amplicon in RA-treated, but not DMSO-treated control 
cells, indicating that the RA pathway had been successfully activated. Data are 
representative of three independent experiments. *denotes significance (p<0.05). 
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3.2 Frizzled family members Fzd3 and Fzd9 are not 
detected in F9 cells 
 Given the results for Fzd7, the focus expanded to investigating other members of 
the Fzd family in F9 cells, specifically their expression levels in undifferentiated and RA-
induced PrE cells. Although it has been reported that 18 of the 19 Wnt genes and all 10 
members of the Fzd family are expressed in F9 cells [44], our laboratory has shown that 
only Wnt6 is expressed [12]. To re-evaluate the Fzd data [44], F9 cells were treated with 
RA to induce PrE and total RNA was isolated after 3 days and reverse-transcribed into 
cDNA for end-point PCR using primers for Fzd1 through Fzd10. Results show amplicons 
for eight of the ten Fzd family members in both undifferentiated and RA-treated F9 cells 
(Fig 3.2A). The expression of Fzd3 and Fzd9 was not detected even after 40 cycles of 
PCR or by altering annealing temperatures. To corroborate that these two latter genes 
were not expressed in F9 cells, mouse tissues known to express these Fzd genes were 
obtained and used in a PCR analysis. Total RNA was collected from mouse tissues 
known to express Fzd3 and Fzd9 (dermis and hippocampus, respectively) and reverse-
transcribed into cDNA to be used for end-point PCR with Fzd3 (Fig 3.2B) and Fzd9 
primers (Fig. 3.2C). That the primers amplify a product in the cDNA of their respective 
positive control samples, but not in cDNA from F9 cells, indicates that these two Fzd 
genes were not detected by end-point PCR in F9 cells and are likely not expressed by this 
cell line. 
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Figure 3.2 Eight of the ten known Fzd genes are expressed in F9 cells. Total RNA was 
collected from F9 cells treated with either RA or DMSO for 3 days (A) or from mouse 
dermis (B) and hippocampus (C) and used as template for RT-PCR. (A) Agarose gels 
showing amplicons corresponding to the predicted size of each Fzd amplicon. Amplicons 
are present in both undifferentiated (DMSO) cells and in cells treated with RA. Between 
35-40 PCR cycles were used to detecte the Fzd transcripts. Amplicons were purified and 
sequenced to confirm their identity. (B) Fzd3 amplicons were detected in mouse dermal 
tissue isolated from three mouse pups of the same litter. The dermis is known to express 
Fzd3 during development and was used as a positive control for the Fzd3 primers tested 
with the F9 cells. (C) A Fzd9 amplicon was detected in mouse hippocampal tissue. The 
mouse hippocampus is known to express Fzd9 and was used a positive control for the 
Fzd9 primers tested with the F9 cells. Data are representative of three independent 
experiments. 
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3.3 qRT-PCR analysis of Fzd transcripts in F9 cells 
 Detecting expression of eight of the 10 Fzd genes in F9 cells prompted further 
analysis to determine if the genes were RA-responsive. The Fzd amplicons shown in Fig. 
3.2 were detected using 40 cycles of PCR, and as such subtle differences in expression of 
each gene between the undifferentiated and RA-treated cells would not be detectable at 
such a high cycle number. qRT-PCR analysis was therefore necessary to determine if the 
Fzds were responsive to RA. To address this, F9 cells were treated with DMSO or RA for 
3 days and total RNA was isolated and reverse-transcribed into cDNA for qRT-PCR. 
Results show that Fzd1, 4, and 8 were significantly upregulated by RA treatment, 
showing a 9.82, 4.86, and 3.69-fold increase in expression relative to control, respectively 
(Fig 3.3, Appendix 2). Fzd2 and Fzd6 showed a slight increase in expression after 
exposure to RA, but neither was statistically significant. The expression of Fzd5 and 
Fzd10 was lower following RA treatment, showing a 0.52 and 0.61 fold-decrease relative 
to control, respectively, however this decrease in expression was not statistically 
significant (Fig. 3.3). Thus, while it appears Fzd1, 4 and 8 genes are RA-responsive, Fzd 
2, 5, 6, 7 and 10 were not. Interestingly, Fzd7 is the most abundantly expressed of the Fzd 
mRNAs detected in undifferentiated F9 cells.  
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Figure 3.3 Fzd receptor expression in response to RA treatment. (A) qRT-PCR analysis 
was used to determine the gene expression profile of Fzd receptors relative to the control 
gene L14 in response to RA. Results show Fzd1, 4 and 8 are significantly upregulated by 
RA at 3 days (9.82, 4.86, and 3.69 fold up-regulation relative to DMSO control cells, 
respectively). The expression of Fzd2, 5, 6, 7 and 10 does not change significantly at 3 
days of RA exposure. Fzd7 is the most abundantly expressed Fzd gene in undifferentiated 
F9 cells. Asterisks denote significant difference (p≤0.05). Data represents the mean and 
standard error of three independent experiments. For fold-changes in Fzd mRNA 
expression relative to DMSO, see Appendix 2. 
28 
 
 
 
  
A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.02
0.04
0.06
0.08
0.1
0.12
Fzd1 Fzd2 Fzd4 Fzd5 Fzd6 Fzd7 Fzd8 Fzd10
N
o
rm
al
iz
ed
 F
zd
 m
R
N
A
 
Ex
p
re
ss
io
n
 (
2
-Δ
C
t )
 
DMSO 
RA 
 * 
* 
* 
29 
 
 
 
3.4 Knockdown of Fzd7 does not inhibit RA-induced 
primitive endoderm differentiation 
 qRT-PCR analysis of the Fzd receptors detected in F9 cells showed that Fzd 1, 4, 
and 8 are upregulated in response to RA, with Fzd1 showing the greatest increase in this 
group after three days of RA treatment. Although Fzd7 was not significantly upregulated 
by RA, its expression in undifferentiated cells relative to the endogenous control 
indicates that Fzd7 is the most abundantly expressed Fzd and this is in agreement with 
the expression profile of Fzd7 in NT2/D1 embryonal carcinoma cells [45]. Given this 
relatively high expression of Fzd7 in F9 cells, and the fact that WNT6 conditioned 
medium differentiates F9 cells into PrE, I predicted that FZD7 was the WNT6 receptor, 
which when activated initiates canonical WNT/β-catenin signalling in F9 cells. To test 
this, it was necessary to determine if cells could be induced to differentiate into PrE in the 
absence of Fzd7. FZD7 was also chosen as a candidate receptor involved in PrE 
differentiation because of its role in activation of both the canonical and non-canonical 
WNT pathways in the same cell type [18]. As both canonical WNT and WNT/PCP 
signalling have been reported as necessary for ExE formation [13, 17] I was anticipating 
that FZD7 was involved in activation of both pathways during the differentiation process. 
If my hypothesis was correct and FZD7 binds WNT6 and transduces a differentiation 
signal, then depleting cells of Fzd7 should reduce PrE differentiation. 
 To address the role of FZD7 in PrE differentiation, F9 cells were transfected with 
Fzd7 short interfering RNA (siRNA) to knock down endogenous Fzd7 transcripts. F9 
cells were transfected with Fzd7 siRNA or non-targeting control siRNA and treated with 
RA for 3 days. Protein lysates were harvested for immunblot analysis using the TROMA-
1 antibody as a marker for PrE differentiation. The TROMA-1 antibody binds to 
Cytokeratin A, an intermediate filament protein that is used as a molecular readout for 
extraembryonic endoderm differentiation [9]. Immunoblot analysis with the TROMA-1 
antibody indicates that cytokeratin-A positive intermediate filaments were present at 
approximately equal amounts in all RA-treated cells, including those transfected with 
Fzd7 siRNA or non-targeting control siRNA (Fig 3.4A). Densitometry analysis indicates 
that TROMA-1 levels were not significantly different due to Fzd7 siRNA transfection 
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(Fig 3.4B). qRT-PCR was used to confirm that Fzd7 mRNA levels were reduced in  Fzd7 
siRNA-transfected cells relative to non-targeting control siRNA transfected cells (Fig 
3.5C). The results indicate that reducing the message encoding the FZD7 receptor using a 
siRNA approach does not have a detrimental effect on PrE differentiation as indicated by 
the strong TROMA-1 signal. Taken together, it would appear that these results do not 
support the hypothesis that FZD7 is a receptor necessary for PrE differentiation. 
Nevertheless, given the functional redundacy issue reported for the Fzd receptors [46], it 
is entirely possible Fzd7 is the receptor, but when absent one or more other receptors can 
serve in its place. Alternatively, knockdown of Fzd7 may not be an effective means of 
reducing FZD7 protein and this is discussed in Chapter 4.2 
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Figure 3.4 F9 cells transfected with Fzd7 siRNA are able to form primitive endoderm. F9 
cells were transfected with Fzd7 siRNA or non-targeting control siRNA and treated with 
RA for 3 days. Protein lysates were collected from each for immunoblot analysis with the 
TROMA-1 antibody (A and B). Total RNA was also collected from cells transfected with 
Fzd7 siRNA and non-targeting control siRNA, and RNA was reverse transcribed into 
cDNA for qRT-PCR analysis to confirm that Fzd7 siRNA specifically targets the Fzd7 
transcript (C). (A) Immunoblot results show that TROMA-1 levels in Fzd7 siRNA 
transfected cells were approximately equal to those in the non-targeting control siRNA 
transfected cells after treatment with RA, and cells treated with RA alone. Antibodies 
against β-actin were used to ensure equal loading in all lanes. (B) Densitometry analysis 
shows that TROMA-1 levels were not significantly different in RA-treated cells 
transfected with Fzd7 siRNA compared to non-targeting control-transfected cells treated 
with RA. Densitometry data was collected by comparing the TROMA-1/β-actin ratio in 
each sample. (C) qRT-PCR analysis indicates that Fzd7 mRNA expression was 
significantly reduced relative to levels in non-targeting control siRNA transfected cells. 
Data represent the mean and standard error of three independent experiments (p<0.05). 
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3.5 Overexpression of Fzd7 activates canonical Wnt/β-
catenin signalling in F9 cells but is not sufficient to 
induce PrE 
 The previous results indicate that knock down of Fzd7 does not attenuate RA-
induced PrE differentiation. If in F9 cells FZD7 is the only receptor for WNT6, and Wnt6 
is the only Wnt detected in these cells during RA-induced differentiation, then knocking 
down Fzd7 should have a detrimental effect on the appearance of PrE differentiation 
markers. However this was not the case, as immunoblot results with the TROMA-1 
antibody indicate that Cytokeratin A levels were not reduced by the Fzd7 siRNA 
treatment. This raised the question as to whether or not Fzd7 was actually the receptor 
involved in differentiation. Since previous results from the Kelly lab suggested that Fzd7 
overexpression was sufficient to induce PrE and this is accompanied by inactivation of 
GSK3, I decided to confirm these results and show that overexpression of Fzd7 induces 
differentiation. 
 If overexpression of Fzd7 is sufficient to activate canonical Wnt signalling 
required for PrE formation, then increased β-catenin/TCF/LEF transcriptional activity 
should be detected in cells overexpressing Fzd7. To test this, F9 cells transfected with 
Fzd7 were analyzed for β-catenin/TCF/LEF-dependent transcription using the Dual-
Luciferase® reporter assay system. Cells were co-transfected with pBARL(β-Catenin-
activated reporter luciferase) to detect activation of TCF/LEF-dependent transcription 
and pRL-TK (Renilla luciferase) plasmids, and either Fzd7 or pcDNA3.1-empty vector 
(EV). Cells co-transfected with pBARL and pRL-TK and treated with RA or DMSO were 
used as positive and negative controls, respectively. pRL-TK was used to normalized 
luciferase values. Relative to the DMSO-treated cells, results indicate that cells treated 
with RA or transfected with Fzd7 showed a significant increase in luciferase activity 
(4.32 and 3.06-fold higher luciferase activity, respectively). DMSO and empty-vector 
transfected cells both exhibit approximately equal levels of luciferase activity (Fig. 3.5A). 
Thus, the results would indicate that overexpressing Fzd7 is sufficient for activation of β-
catenin/TCF/LEF-dependent transcription in F9 cells.  
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 Although reducing Fzd7 mRNA with siRNA does not inhibit PrE differentiation, 
overexpression of Fzd7 activates the canonical Wnt/-catenin signalling pathway and 
therefore should induce PrE in a manner similar to Wnt6. To test this F9 cells were 
transfected with Fzd7 or pcDNA3.1 and selected with G418 for 5 days, or treated with 
RA or DMSO as positive and negative controls for differentiation, respectively. Protein 
lysates were collected and used for immunoblot analysis with the TROMA-1 antibody as 
a marker for PrE differentiation. Total RNA was also collected, reverse-transcribed into 
cDNA, and used for qRT-PCR with Fzd7 primers to verify that Fzd7 was being 
overexpressed. qRT-PCR results show that Fzd7 mRNA is expressed 163-fold higher in 
Fzd7-transfected cells relative to empty-vector control (Fig. 3.7B). Immunoblot analysis 
indicated that levels of TROMA-1 in Fzd7 transfected cells did not change significantly 
and were similar to those detected in DMSO-treated and pcDNA3.1-transfected cells (Fig 
3.7C). Densitometry was not performed as TROMA-1 levels in DMSO, Fzd7, and 
pcDNA3.1 lysates were not detectable above the background noise. That a TROMA-1 
signal was detected in lysates of RA-treated cells, but was barely visible in DMSO-
treated cells, would indicate that F9 cells had successfully differentiated into PrE due to 
RA treatment and that the TROMA-1 antibody was functioning as expected.   
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Figure 3.5 Overexpression of Fzd7 activates -catenin/TCF/LEF-dependent transcription 
in F9 cells, but does not alter levels of the PrE marker Cytokeratin A. (A) F9 cells were 
co-transfected with pBARL (β-catenin activated reporter luciferase) and pRL-TK(Renilla 
luciferase) plasmids, as well as either Fzd7 or pcDNA31.-empty vector, or treated with RA 
or DMSO for 48 hours. Lysates were collected and processed for luciferase activity. Cells 
treated with RA or Fzd7 show a 4.32 and a 3.06 fold-increase in luciferase activity 
respectively, relative to DMSO-treated cells (Appendix 3). (B) F9 cells were transfected 
with pcDNA3.1 or Fzd7, or treated with DMSO or RA and total RNA or protein lysate 
was collected after 5 days. Total RNA from pcDNA3.1 and Fzd7-transfected cells was 
collected, reverse-transcribed, and used for qRT-PCR analysis with primers for Fzd7. 
Results show that Fzd7 mRNA  is expressed 163-fold higher in Fzd7-transfected cells 
relative to pcDNA3.1-transfected cells. (C) Representative blot showing a TROMA-1 
signal in RA-treated, but not in DMSO-treated, Fzd7 or pcDNA3.1-transfected cells. Data 
represent the mean and standard error of three independent experiments (p<0.05). 
Luciferase activity was calculated by normalizing firefly luciferase activity to Renilla 
activity. For fold changes in TCF/LEF luciferase activity relative to DMSO, see Appendix 
3. 
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3.6 Dkk1 mRNA expression is induced by RA treatment and 
Wnt6 overexpression 
 As previously mentioned, studies from the Kelly lab have demonstrated that 
ectopic expression of Fzd7 in F9 cells is sufficient to induce PrE differentiation and also 
to inactivate GSK-3 (Benjamin Cadesky, unpublished). This is supported by the results 
from the β-catenin/TCF/LEF luciferase assay, where overexpression of Fzd7 induced β-
catenin/TCF/LEF-dependent transcription (Fig 3.5A). However, these results are not 
corroborated by the Fzd7 knockdown (Fig 3.4A) or the overexpression studies (Fig. 
3.5C). Together, it would appear that these results do not support the hypothesis that 
FZD7 is a receptor necessary for binding WNT6 during RA-induced differentiation. 
Nevertheless, the hypothesis may still hold true if the Fzd7 knockdown was compensated 
by another Fzd receptor acting in a functionally redundant manner, and/or the fact that 
my overexpression experiments were ineffective in producing enough protein necesssary 
to induce differentiation. Whatever the case, canonical Wnt signalling in F9 cells is 
necessary and sufficient for ExE formation and thus inhibiting the interaction between the 
ligand and the FZD receptor should inhibit the differentiation process. In addition, 
TCF/LEF-dependent transcription is necessary for F9 cells to differentiate in response to 
RA, and as other pathways can crosstalk with the Wnt pathway and cause β-catenin 
stabilization downstream of FZD receptors [43], I wanted to confirm the necessity of the 
pathway by blocking its activation at the level of the receptors. As attempts to inhibit 
differentiation by targeting Fzd7 were unsuccessful, a broader approach was taken to 
inhibit WNTsignalling at the cell surface. Antibodies that specifically target FZD 
receptors are currently in development, and are not available. The lack of Frizzled-
specific antibodies/chemical inhibitors prompted me to employ proteins known to 
antagonize WNT signalling [47].   
 In a microarray profiling study using F9 cells, Gudas et al. identified two RA-
target genes Dab2 and sFRP5, both of which encode inhibitors of WNT signalling [40]. 
Interestingly, F9 cells induced to differentiate into VE are not responsive to WNT 
ligands, suggesting a blockade in WNT signalling accompanies differentiation [42]. 
Thus, it is plausible that F9 cells upregulate the expression of inhibitors of WNT 
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signalling in response to RA. To address this I examined Dickkopf-1 (DKK1), a specific 
inhibitor of canonical Wnt signalling for the following reasons. First, DKK1 is a secreted 
antagonist of WNT signalling, and therefore inhibits signalling at the level of the receptor 
and its ligand. Second, DKK1 is reported to specifically inhibit canonical WNT 
signalling as it binds a WNT co-receptor obligatory for canonical pathway activation 
[13]. In addition to binding FZD receptors, WNT ligands also bind to the single-span 
transmembrane LDL receptor-related protein 5/6 (LRP5/6) co-receptor to form a WNT-
FZD-LRP5/6 ternary complex [39]. This interaction between WNT, FZD, and an LRP 
co-receptor is obligatory for activation of the canonical WNT pathway [48]. Third, Dkk1 
expression is regulated by the β-catenin/TCF-LEF transcriptional complex in many cell 
lines, and several TCF-binding element (TBE) consensus sites have been identified 
within a highly conserved region 1kb upstream of the transcription start site in the human 
and mouse Dkk1 promoters [35]. Finally, Dkk1 is reportedly expressed in F9 cells 
induced to differentiate into VE [42].  
 With the above in mind, I sought to determine if Dkk1 expression is upregulated 
during PrE differentiation. To address this, the expression level of Dkk1 was analyzed 
over a four day period of RA-treatment. F9 cells were treated with 10
-7 
M RA for 1-4 
days, or DMSO for 4 days and total RNA was collected and reverse-transcribed into 
cDNA for qRT-PCR analysis. qRT-PCR results indicate that Dkk1 expression is 
significantly increased at day 3 and 4 of RA treatment relative to DMSO control cells 
(Fig 3.6A). Expression of Dkk1 mRNA increased by 118 and 611-fold in cells treated 
with RA for 3 and 4 days, respectively, compared to DMSO control cells (Fig 3.6A). 
These results would indicate that the Dkk1 gene is RA-responsive, and is either a direct 
target of the RA pathway, or is regulated by a transcription factor that is downstream of 
RA signalling. 
 As Wnt6 is upregulated in F9 cells in response to RA, and Wnt6 overexpression or 
WNT6 conditioned medium is sufficient to induce PrE through activation of canonical 
WNT signalling [12], I decided to determine if overexpression of Wnt6 could also cause 
an increase in Dkk1 expression similar to that induced by RA. F9 cells were transfected 
with Wnt6 or pcDNA3.1, treated with G418 for 4 days, and total RNA was collected and 
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reverse-transcribed into cDNA to be used as template for qRT-PCR analysis. Results 
show that Dkk1 expression increased by 2.92-fold in cells transfected with Wnt6 
compared to empty vector-transfected cells (Fig 3.6B). To confirm that Wnt6 was being 
overexpressed, the same cDNAs used in qRT-PCR with Dkk1 primers were also used for 
end-point PCR with primers for Wnt6. Results show the presence of a Wnt6 amplicon in 
cells transfected with pcDNA3.1-Wnt6 (Fig 3.6C). An amplicon corresponding to Wnt6 
was not detected in cDNA from empty-vector transfected cells, however, the presence of 
an L14 amplicon indicated that cDNA was available for amplification. Taken together, 
these results demonstrate that the Dkk1 gene is induced by RA treatment and by 
overexpression of Wnt6 alone.  
 That Dkk1 expression is greatly increased in the presence of RA, and only slightly 
increased due to Wnt6 overexpression, prompted subsequent analysis of the mouse Dkk1 
promoter region for conserved Retinoic Acid Response Elements (RARE) binding sites, 
the presence of which might explain the 611-fold upregulation of Dkk1 by RA. The 
Ensembl Genome Browser Regulatory Build was used to identify putative regulatory 
regions upstream of the Dkk1 transcription start site. A 961bp sequence was predicted as 
the Dkk1 promoter region and this sequence was used to identify potential RARE 
consensus DNA motifs. That two conserved RARE nucleotide sequences were found 
within this region, spaced 9bp apart (Fig3.6D), would suggest the potential for regulation 
of the Dkk1 gene by RAR-RXR homo/heterodimers. 
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Figure 3.6 Dkk1 is induced by overexpression of Wnt6. Total RNA was isolated from 
cells treated with RA (positive control) for 1-4 days and reverse-transcribed into cDNA 
(A). Total RNA was also isolated from F9 cells transfected with pcDNA3.1-Wnt6 and 
reverse-transcribed into cDNA (B and C). qRT-PCR was performed using primers for 
Dkk1(A) and qRT-PCR and end point-PCR were performed using primers for Wnt6 (B 
and C). (A) qRT-PCR results indicate the expression of Dkk1 is significantly increased at 
3 and 4 days after RA treatment compared to DMSO-treated cells or cells treated with 
RA for 1 day. Expression of Dkk1 at day 2 of RA treatment is not signicantly different 
compared to DMSO-treated cells or cells treated with RA for 1 or 3 days but was 
significantly different from Dkk1 expression at 4 days post-RA treatment. 2
-ΔΔCt 
analysis 
indicates that compared to DMSO-treated cells, Dkk1 levels were increased by 119 and 
611-fold at 3 and 4 days post-RA treatment, respectively (Appendix 4). Expression of 
Dkk1 mRNA was normalized to the expression of L14 mRNA.  (B) qRT-PCR analysis 
indicates that Dkk1 mRNA expression increased by 2.92-fold in Wnt6-transfected cells 
compared to the empty vector control. (C) End-point PCR using the same cDNA samples 
in (B) show the presence of a Wnt6 amplicon in cells transfected with pcDNA3.1-Wnt6 
compared to empty vector control. (D) In silico analysis of the predicted Dkk1 promoter 
region. The presence of two conserved RARE motifs within the predicted promoter 
region suggests possible regulation by RAR-RXR nuclear transcription factors. Data 
represent the mean and standard error of three independent experiments. Letters and * 
denote significance (p<0.05). For fold changes in Dkk1 mRNA expression relative to 
DMSO or empty vector treatments, see Appendix 4. 
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Mouse dickkopf homolog 1 (Xenopus laevis) 
ENSEMBL Regulatory Region ENSMUSR00000425059-Positive strand 
 
CTCTTCAAAAGCCCCTTAAGCGCGCTGCTCTTAATGCAGTGATTCCAAACACACCCCAAA 
TCTCACACACCTAGATCTTTCTGAGACCCCCGTCGGGATCACAGCACCCCTCTTACCTGG 
TAGTTGTCAAGAGTCTGGTACTTGTTCCCGCCCTCATAGAGAACTCCCGGCGCCACACTG 
ACAGCAGAGCCCGGCTGCCCCCCAGCACCACCCAGCGGTGGGGGCAGGTTCTTGATCGCG 
TTGGAATTGATGAGAACTGAGTTCAAGGTGGCACTGGCTCCTAGCAGAGGGAGGCTGCAG 
AGAGCCATCATTGTAAACACGGCCAAGAACCGGACAGCTGCCGCTGCACACACAACCATC 
ATCTCCGAAGGACGCAAACAGGCAAAGGTCAGGAAAAGAGAGGTCACTTTGCACGGCGGC 
TGGCTGCAGAGTCTGGACTGCGGAACCTCAACTTCGGGACCTCCGCTGGTGGAGTCTCTG 
GCTGCCAGGCGCACAGCTCTGCACCGCCACCGCCACCTCTGGCTGCCTTTATACTCAGGC 
TCCCAGCCCTCCCAGCTCCTCAGGGAAGACAACAAAGCCGGGATGGGATTTCAAAGCTTT 
GGGAGGAGCTGGGAGGGGGAGTGTTTGTGTGTCGGAAGCAGGGAGGACTTTGACACTCTC 
CCCTCGCCCCTCCCTTGCACTGTGGTCCCCTTGTCCAGCTCACCTTAGAGTGTGGGTCAC 
TAGAGCACTAGAGCATTAGAGCCTAGCCCAAACTTATAAATAAATAAATAAATAAATAAA 
TAAATGGCGGGAGGGTGCACTCTGTGAGCTTGAGTGTTCTGCTGTGGGGCTGGGTTAGTT 
CTGTCTGAAATCCTTGTCAGAGTTAAAAGTGATAGAA 
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3.7 Ectopic expression of canonical WNT antagonist 
Dickkopf-1 attenuates primitive endoderm differentiation 
 The previous results indicate that Dkk1 is expressed in F9 cells and is upregulated 
during RA differentiation. After determinining the expression profile of Dkk1 during PrE 
differentiation, the next step was to assess the effect ectopically expressing Dkk1 would 
have on F9 cells induced to differentiate by RA. As canonical Wnt/β-catenin signalling 
has been reported as necessary for F9 cell differentiation [13], it is expected that if Dkk1 
is expressed early enough during the differentation process, it would inhibit canonical 
Wnt signalling and subsequently attenuate/inhibit differentiation. 
 To determine the effect of Dkk1 on PrE differentiation, F9 cells were transfected 
with a myc-tagged human Dickkopf-1 (MYC-DKK1) construct and selected with G418, 
then treated with RA for 4 days to induce PrE. Protein lysates were collected and 
processed for immunoblot analysis with the TROMA-1 antibody to determine if cells had 
differentiated into PrE. Immunoblot analysis showed that Cytokeratin A was expressed in 
the positive controls treated with RA or transfected with empty vector and treated with 
RA (Fig. 3.7A). Cytokeratin A levels were reduced in cells transfected with the MYC-
DKK1 construct and treated with RA (Fig 3.8A). Densitometry analysis confirmed this 
significant decrease in TROMA-1 levels in cells transfected with MYC-DKK1 and treated 
with RA compared to cells transfected with empty vector and treated with RA (Fig. 
3.7B). The apparent reduction in TROMA-1 signal in cells transfected with empty vector 
and treated with RA compared to cells treated with RA alone would indicate that 
transfection had a detrimental effect on differentiation. Therefore, all further experiments 
were conducted using transfected positive (ie. pcDNA3.1 +RA) and negative controls (i.e. 
pcDNA3.1 +DMSO) to control for these transfection effects. To corroborate the 
TROMA-1 immunoblot data, this experiment was repeated using another marker of PrE 
differentiation [49]. Thus, since ectopic MYC-DKK1 expression can inhibit 
differentiation as evident by a reduction in Cytokeratin A levels, then its overexpression 
should also negatively impact Dab2 expression. Total RNA was collected and reverse-
transcribed into cDNA and used for qRT-PCR analysis with Dab2 primers. qRT-PCR 
analysis showed that relative to controls, Dab2 was upregulated by 141-fold in empty 
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vector transfected and RA-treated cells and by 118-fold in cells transfected with MYC-
DKK1 and treated with RA (Fig 3.7C). Taken together, these results indicate that 
ectopically expressing MYC-DKK1 in undifferentiated F9 cells reduces their ability to 
differentiate into PrE when treated with RA. 
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Figure 3.7 Cells transfected with MYC-DKK1 show decreased expression of PrE 
markers. (A) F9 cells were transfected with pcDNA3.1 or MYC-DKK1 and treated with 
DMSO or RA, or treated with DMSO or RA alone, and protein lysates were collected for 
immunoblot analysis with the TROMA-1 antibody. Immunoblot analysis shows a 
TROMA-1 signal in cells transfected with pcDNA3.1 and treated with RA and cells 
treated with RA alone. This signal is also present in cells transfected with MYC-DKK1 
and treated with RA, however, its intensity is reduced in comparison to the positive 
controls (RA and pcDNA3.1+RA), and is closer to that seen in Lane1 (DMSO –treated 
cells). β-actin served as a loading control. (B) Densitometry analysis confirmed that there 
was a significant reduction in TROMA-1 levels in cells transfected with MYC-DKK1 and 
treated with RA, compared to cells transfected with empty vector and treated with RA. 
(C) Total RNA was collected from F9 cells transfected with MYC-DKK1 and treated with 
RA or transfected with empty vector and treated with DMSO or RA, and qRT-PCR 
analysis was performed using Dab2 primers. Results show that Dab2 mRNA expression 
was significantly reduced (by approximately 23-fold) in MYC-DKK1 transfected, RA-
treated cells compared to empty vector transfected, RA-treated cells (Appendix 5). Data 
represent the mean and standard error of three independent experiments. * denotes 
significance (p<0.05). For fold changes in Dab2 expression relative to empty vector 
transfected, DMSO-treated control, see Appendix 5. 
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3.8 MYC-DKK1 conditioned medium attenuates PrE 
formation 
 The results from the overexpression of MYC-DKK1 indicate that ectopically 
expressing a construct encoding a secreted antagonist of canonical WNT/β-catenin 
signalling in undifferentiated F9 cells attenuates the ability of RA to induce the PrE 
phenotype. This confirms an earlier study that reported that canonical WNT/-catenin 
signalling was necessary for RA-induced PrE differentiation [13] . Furthermore, my 
results show that differentiation is blocked  when WNT is prevented from forming a 
WNT-FZD-LRP5/6 receptor complex on the plasma membrane. To corroborate this data, 
MYC-DKK1 conditioned medium was generated using HEK-293 cells to examine 
whether ectopically applying the protein to F9 cells mimics the effect of overexpression 
of MYC-DKK1 on differentiation.  
 Briefly, HEK-293 cells were transfected with pcDNA3.1 or MYC-DKK1, and 
medium was collected after 48 hours, filter sterilized, and concentrated. HEK-293 protein 
lysates were also collected for immunoblot analysis with the anti-c-Myc antibody (9E10) 
to confirm that the cells were translating the MYC-DKK1 transcripts. A band at 
approximately 39kD corresponding to the MW of MYC-DKK1 was detected in HEK-293 
cells transfected with the MYC-DKK1 construct, but not in cells transfected with the 
empty-vector (Fig. 3.9A). To confirm that the HEK-293 cells were secreting the protein, 
the medium generated from these cells was concentrated and used for immunoblot 
analysis. If the MYC-DKK1 protein is being translated and secreted by the cells, then the 
9E10 antibody should recognize the MYC-epitope both in cell lysates and in the medium. 
The concentrated medium  was used for immunoblot analysis and a 39kD band was 
detected in the  medium from cells transfected with MYC-DKK1, but not the empty 
vector (Fig. 3.8B). The MYC-DKK1 conditioned medium was applied to F9 cells in the 
presence of DMSO or RA to see if it would mimic the effect of expressing MYC-DKK1 
on differentiation. Protein lysates were collected for immunoblot analysis and results 
showed a TROMA-1 signal present in cells treated with the empty vector-conditioned 
medium and RA, but absent in cells treated with this conditioned medium and DMSO.  
Thus, the conditioned medium did not contain factors that could induce differentiation on 
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its own (Fig. 3.8C). A TROMA-1 signal was also present in cells treated with MYC-
DKK1 conditioned medium and treated with RA, however, its intensity was reduced 
compared to that seen in cells treated with the empty vector-conditioned medium and RA 
(Fig 3.8C). Densitometry analysis confirmed that the reduction of TROMA-1 seen in 
cells treated with MYC-DKK1 conditioned medium and RA was significant compared to 
cells treated with the empty vector-conditioned medium and RA (Fig. 3.8D). Taken 
together, these results indicate that the HEK-293 cells were a useful vehicle for the 
production and secretion of the MYC-DKK1 protein. More importantly, applying the 
ectopically expressed protein on F9 cells in the presence of RA attenuates the ability of 
RA to induce PrE differentiation.  
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Figure 3.8 Ectopically expressed MYC-DKK1 attenuates RA-induced PrE differentiation 
of F9 cells. HEK-293 cells were transfected with pcDNA3.1 or MYC-DKK1, and protein 
lysates and media were collected for immunoblot analysis with the 9E10 antibody to 
determine if the cells were translating (A) and secreting (B) the Myc-tagged DKK1 
protein. (A) Immunoblot analysis of lysates with the 9E10 antibody shows the ecoptic 
DKK1 protein present in cells transfected with MYC-DKK1, but not pcDNA3.1 (N=2), 
(B) Conditioned medium collected from these cells was filter sterilized, concentrated and 
used for immunoblot analysis with the 9E10 antibody to confirm that the MYC-DKK1 
protein was secreted into the medium. The unorthodox bands pattern is likely an artifact 
of the concentration process, perhaps due to increased salt concentration (N=2). (C) A 
representative blot showing TROMA-1 levels are reduced in cells treated with the MYC-
DKK1 CM and RA compared to pcDNA3.1-CM and RA. F9 cells co-treated with the 
concentrated CM from HEK-293 cells and either DMSO or RA were collected for 
immunoblot analysis with the TROMA-1 antibody. (D) Densitometry analysis confirmed 
that there was a significant decrease in TROMA-1 signal (0.39-fold)  in cells co-treated 
with MYC-DKK1 CM and RA, compared to cells co-treated with pcDNA3.1 CM and 
RA. Data is representative of three independent experiments, except for (A) and (B) 
(N=2).* denotes significance (p<0.05). 
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Chapter 3  
4 Discussion 
 The WNT signalling pathway is ancient and evolutionarily conserved in 
Metazoans and one that is required for proper embryonic development, differentiation of 
stem cells, organogenesis and tissue patterning. The result of a WNT ligand binding to its 
cognate FZD receptor is the initiation of one or several intracellular signalling cascades, 
which include the canonical WNT/β-catenin-dependent pathway and the non-canonical, 
β-catenin-independent Planar Cell Polarity (PCP) and WNT/Ca2+ pathways. There are 10 
different Fzd receptors and 19 Wnts that have been identified in vertebrates, allowing for 
a remarkable number of receptor-ligand combinations that complicates the understanding 
of how one particular WNT pathway can be activated preferentially over another. The 
activation of one signalling branch over another is thought to depend on several factors 
such as the intrinsic properties of WNTs and FZDs themselves, as well as expression of 
receptors and co-receptors in the cellular context of study [28]. 
 In this study, F9 cells were used to investigate the role of the canonical WNT/β-
catenin signalling pathway, and specifically the role of FZD receptors, in specifying a set 
of naïve cells to adopt an epithelial state known as primitive endoderm. F9 cells also 
utilize the PCP and WNT/Ca
2+
 pathways during differentiation; however these pathways 
were not investigated in this study. The PCP pathway is reported to control the oriented 
migration of PE cells [17], where WNT binding to FZD, like that in canonical -catenin 
signalling, initiates DVL activation. Unlike, -catenin-dependent signalling, however, 
this binding leads to activation of RHO-ROCK and RAC-JNK signalling, which causes 
cytoskeletal changes that mediate cell polarity and cell movements. Although the PCP 
pathway was not investigated in this study, its importance should not be underrated as it 
is key to specifying gastrulation, one of the most important developmental and 
morphogenetic processes [14]. The other known PCP pathway involves Ca
2+ 
signalling, 
and was discovered when some WNT and FZD receptors were found to stimulate 
intracellular calcium ion release from the endoplasmic reticulum [50]. WNT/Ca
2+ 
signalling is thought to depend on the action of G-proteins, Ca
2+
/calmodulin-dependent 
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protein kinase, and Protein Kinase C to regulate convergent extension movements along 
the anterior-posterior axis during gastrulation, but again this pathway was not 
investigated in this study.  
 The most studied of the WNT pathways and one that was the focus of this study is 
the canonical WNT/β-catenin-dependent pathway. F9 cells differentiate into PrE when 
treated with RA, and this differentiation is accompanied by the upregulation of Wnt6 and 
activation of the canonical WNT/β-catenin pathway [12]. Wnt6 is upregulated by the 
transcription factors GATA6 and FOXA2. Gata6 is a direct target gene of RA, and 
FoxA2 expression is induced by GATA6. Both GATA6 and FOXA2 bind the promoter of 
Wnt6 in F9 cells to activate its transcription [51]. Thus, Wnt6 is upregulated during RA 
induced differentiation; however the receptor responsible for binding WNT6 and 
transducing this differentiation signal is heretofore unknown. 
 
4.1 Transcriptional response of Frizzled genes during PrE 
differentiation 
 Since RA causes an increase in the expression of Wnt6, which in turn activates 
canonical WNT signalling, and if FZD7 is the receptor that binds WNT6 to activate this 
pathway, then I would expect Fzd7 mRNA to be present in undifferentiated cells, 
awaiting translation and trafficking to the cell membrane in order to receive the WNT 
signal. That Fzd7 mRNA was detected in undifferentiated F9 cells and throughout 
differentiation into both PrE and PE supports this idea. Data from the Kelly laboratory 
has shown that Fzd7 expression is significantly increased in F9 cells following RA 
treatment (Benjamin Cadesky, unpublished) however these results were not confirmed in 
this study and is attributed to differences in the days that cells were exposed to RA. This 
prompted investigation of other members of the Fzd family to determine if they are 
expressed in F9 cells and if there is a particular member that is preferentially increased in 
response to RA. Okoye et al. report that all Fzds and 18 out of 19 Wnts are expressed in 
undifferentiated F9 cells. This, however, contradicts the Fzd expression data in this study 
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and with previous findings from the Kelly lab, which show that only eight out of the ten 
Fzds are expressed in F9 cells, and that Wnt6 is the only expressed Wnt. These 
contradictory results are likely due to amplification of genomic material/contaminants 
leading to false positive signals seen in the Okoye et al. report. 
 My results show that three of the eight Fzd genes were significantly upregulated 
by RA. This transcriptional response to RA has also been shown in NTERA-2 human 
embryonal carcinoma cells (NT2/D1) [45, 52]. Interestingly, treatment of human 
embryonal carcinoma NT2/D1 cells with RA causes upregulation of several Wnt and Fzd 
genes, most notably being Fzd7 [45], which is in agreement with my results. The 
transcriptional response to RA indicates that the RA pathway regulates Fzd receptor 
encoding genes, but there may be further, more refined regulation involving canonical 
WNT/β-catenin signalling. Both positive and negative regulation of Fzd expression by 
the canonical WNT/β-catenin signalling pathway was reported when human embryonal 
carcinoma cells were treated with WNT-3A conditioned medium [53, 54]. Thus, it is 
tempting to speculate that the observed change in Fzd receptor expression during PrE 
differentiation is the indirect result of RA signalling and the direct result caused by 
TCF/LEF target gene activation induced by Wnt6.  
 Regardless of regulation, the transcriptional response is the upregulation of these 
genes and subsequent translation of the message and trafficking of the receptor to the cell 
membrane, which would be present to receive WNT6. Binding would initiate activation 
of the canonical WNT/β-catenin signalling pathway and facilitate the transition from the 
undifferentiated state into PrE. That WNT6 conditioned medium is sufficient to activate 
canonical WNT/β-catenin signalling and differentiate cells into PrE [12], would suggest 
that receptors are already in place in undifferentiated cells and that transcriptional 
regulation following WNT6 to bind the F9 cell surface induces other Fzd genes to 
activate other signalling pathways needed for differentiation. The results showing Fzd1, 4 
and 8 are upregulated in PrE cells compared to undifferentiated cells would indicate that 
these receptors are preferentially utilized in the PrE state, and may mediate the transition 
from PrE to PE. If that is the case, future studies should focus on blocking the expression 
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of Fzd1, 4 and 8 and determining if this down-regulation would have an effect on the 
transitioning of cells from PrE to PE. 
4.2 Knockdown of Fzd7 does not attenuate PrE 
differentiation 
 The Frizzled gene family encodes receptors for WNT ligands and these receptors 
are therefore the lynchpins in transducing the signals that specify numerous events during 
embryonic, neonate and adult development. Specific FZD receptors and the downstream 
pathways they are coupled to have been studied in various contexts. In the case of the β-
catenin pathway in F9 cells, WNT binding to a FZD receptor and LRP5/6 co-receptor 
initiates this pathway in response to WNT6. Subsequent TCF/LEF target genes are then 
activated that specify cells to adopt a PrE fate. The question remains, however, as to the 
identity of the FZD receptor that initiates this process, especially given the considerable 
promiscuity between WNTs and their FZD receptors [15]. Despite the fact that the 
original hypothesis was that FZD7 is the primary receptor responsible for binding WNT6 
in F9 cells, given that Fzd7 siRNA did not lower Cytokeratin A levels would suggest that 
other FZD receptors can bind WNT6 or that the siRNA did not effectively reduce FZD7 
protein levels. If FZD7 was the sole receptor for WNT6, or the only Fzd expressed in F9 
cells, then knocking it down would attenuate differentiation. However, this was not the 
case, and could be explained by the functional redundancy among FZD receptors or by an 
ineffective knockdown. Towards the end of functional redundancy, it has been shown 
that Drosophila fz and Dfz2 are functionally redundant for canonical WNT/β-catenin 
signalling, as fz loss-of-function mutant flies do not show disrupted canonical signalling 
[46]. Phylogenetic analysis of human Fzd genes groups them into four clusters: Fzd1/2/7, 
Fzd3/6, Fzd5/8 and Fzd4/9/10. As Fzd1, 2 and 7 share 75% sequence identity with each 
other, it is not surprising that there is considerable functional redundancy within this 
particular cluster [23]. Fzd7
-/- 
mice demonstrate a 15% penetrant cardiac phenotype 
compared to Fzd2
-/-
;Fzd7
-/-  
embryos, which display a 100% penetrant convergent 
extension defect and mid-gestational lethality [55]. Fzd7 and Fzd5 are also functionally 
redundant for canonical WNT/-catenin signalling in cell culture, as ectopic expression 
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of Fzd5 in human mesenchymal stem cells (hMSCs) harboring a Fzd7 knockdown can 
rescue TCF/LEF luciferase reporter activity. Conversely, ectopic expression of Fzd7 can 
rescue the same reporter activity in Fzd5 knockdown hMSCs [56]. Interestingly, Fzd5 
was the second most abundantly expressed Fzd in F9 cells and given that it can substitute 
for Fzd7 to fulfill the role of a canonical WNT signalling receptor in another stem cell 
model, its knockdown in combination with Fzd7 in F9 cells may have a detrimental effect 
on differentiation. It is also important to note that Fzd1 displayed the greatest increase in 
expression after RA treatment, and overexpression of chimeric rFz1 and rFz2 receptors 
in F9 cells is sufficient for primitive endoderm differentiation [24, 25]. Due to functional 
redundancy, it is likely that multiple Fzd receptors need to be knocked down 
simultaneously to prevent WNT6 from activating canonical WNT/β-catenin signalling 
and attenuate differentiation into PrE. Thus, it would be interesting to determine if 
knocking down the entire cluster consisting of Fzd1, 2 and 7 in an attempt to abolish 
redundant pathway activation would have an effect on differentiation. In this study, it is 
also possible that Fzd7 mRNA levels were not sufficiently reduced to cause a subsequent 
knockdown of FZD7 protein, as FZD7 protein levels were not assessed in this study 
using an anti-FZD7 antibody, this scenario should not be ruled out. Also, the doubling 
time of F9 cells is approximately eight hours [8] and as a result siRNA could be diluted 
below an effective amount due to cell division. To circumvent this issue, a selectable 
short-hairpin RNA (shRNA) vector could be utilized as a more potent method of RNA 
interference. shRNAs confer several advantages over siRNAs, as they allow for 
constitutive expression of the antisense RNA and continual knockdown of the Fzd in 
question, both circumventing potential problems associated with inadequate knockdown 
time. Additionally, cells that have taken up the vector can be selected, eliminating cells 
that were not successfully transfected. Alternatively, siRNA may not be an effective 
strategy for reducing protein levels and inhibiting differentiation if FZD7 is a stable 
protein. If this is the case, the reduction in protein translation and accumulation that 
follows degradation of the endogenous Fzd7 transcript would not have a significant effect 
on FZD7 protein levels, and it could still be present at sufficient levels to bind WNT6 and 
induce differentiation. As FZD7 protein expression was not examined following siRNA 
transfection, this possibility should not be ruled out. 
55 
 
 
 
4.3 Overexpression of Fzd7 is not sufficient to induce PrE  
  
 The overexpression of Fzd7 has been reported in many types of human cancer. 
Notably, overexpression of Fzd7 is reported in colorectal cancer, hepatocellular 
carcinoma (HCC), and triple-negative breast cancer (TNBC). Knockdown of Fzd7 in 
colorectal cancer cells decreases -catenin/TCF/LEF activity, invasion, and migration. 
Similarly in HCC and TNBC cells, knockdown or inhibition of Fzd7 causes a similar 
reduction in -catenin activity resulting in reduced cell motility and cell proliferation 
[19]. Thus, Fzd7 is thought to confer malignancy via its ability to activate the canonical 
WNT/-catenin signalling pathway. In this study, Fzd7 was overexpressed in F9 cells to 
determine if it could activate the canonical WNT/-catenin pathway and if so, whether 
this activation would be sufficient for PrE differentiation. It was expected that Fzd7 
overexpression would cause activation of canonical signalling, and the results showing 
activation of the TCF/LEF luciferase reporter assay were encouraging. However, that no 
effect was observed on Cytokeratin A levels in an immunoblot assay after five days of 
culturing would suggest the overexpression of Fzd7 was not sufficient to induce PrE. 
Several reasons to explain this discrepancy could be proposed, including the possibility 
that the reporter assay was sensitive to detect activation, but that the overexpression was 
not adequate for the requisite activation of endogenous genes needed to induce these 
naïve cells. Although the TCF/LEF luciferase reporter was activated in cells transfected 
with Fzd7 in comparison to empty vector transfected cells, it is possible that there are 
other explanations for this increase in reporter activity and without demonstrating 
increased FZD7 protein expression transfected cells, alternative explanations for the 
observed reporter activity should not be ruled out. Future studies would, however, need to 
be employed to test these ideas.  
 Why overexpression of Fzd7 did not induce PrE differentiation is not known 
despite the fact that it causes activation of the canonical WNT/-catenin pathway. 
Activation of WNT signalling due to Fzd overexpression is accompanied by the 
recruitment of DVL to the plasma membrane [46]. In Xenopus, certain FZDs are capable 
of activating the canonical WNT pathway/-catenin when injected alone (e.g., Xfz3), 
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while others require the co-injection of a Wnt for pathway activation (e.g., Xfz4 and Xfz7) 
[31]. Thus, it seems that some FZDs activate WNT signalling in a ligand-independent 
fashion when overexpressed, while others require the presence of an appropriate ligand. 
Other studies show that FZDs exist as homodimers when overexpressed and this 
dimerization is associated with activation of the canonical WNT/β-catenin pathway [32]. 
Whether this dimerization is necessary for DVL recruitment is not known [32], but two 
cysteine residues conserved among FZDs and located in the first and second extracellular 
loops, would facilitate intermolecular disulfide bond formation needed for dimer 
formation [14]. Indeed, receptor dimerization and activation has been shown for several 
GPCRs but whether dimerization is necessary and sufficient and occurs in F9 cells is not 
known. Likewise, Fzd7 was not expressed with a Wnt in this study, which may have had 
an effect. Nonetheless overexpression of Fzd7 alone was sufficient to activate TCF/LEF-
dependent transcription demonstrating ligand-independent pathway activation. 
4.4 Role of Dkk1 in ExE differentiation 
 Since overexpression of Fzd7 did not induce PrE, and its knockdown in the 
presence of RA did not inhibit PrE formation, a more widespread approach was taken to 
inhibit canonical WNT/-catenin signalling during differentiation. Rather than attempt to 
inhibit WNT6 from interacting with a single FZD receptor, DKK1 was used to inhibit 
WNT-FZD-LRP5/6 complex formation, which is indispensable for activation of the 
canonical WNT pathway [48]. DKK1 modulates the output of the canonical WNT 
pathway by binding to LRP5/6 and blocking the LRP5/6-WNT interaction, thus 
preventing complex formation between WNT, FZD and LRP5/6 [57]. In addition, DKK1-
mediated inhibition of WNT signalling is enhanced by the presence of the single-pass 
transmembrane protein Kremen1/2 (KRM1/2). KRM2 forms a ternary complex with 
DKK1 and LRP6 and causes rapid endocytosis of LRP6 from the cell membrane [58]. 
The hallmark function of the DKK family of proteins is their ability to modulate WNT 
signalling. Given the highly important role of WNT signalling pathways during 
development, the maintenance of WNT signalling homeostasis by DKK proteins is 
crucial. DKK1 is required for normal antero-posterior axial patterning, limb and vertebral 
formation where Dkk1
-/- 
mice display embryonic lethality showing deletion of anterior 
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head structures, postaxial polysyndactyly, and fused vertebrae. In addition, misexpression 
of Dkk1 is reported in several types of cancer such as Wilm’s tumour, colorectal, and 
HCC [59].   
  The significant upregulation in expression of Dkk1 mRNA in RA-treated F9 cells 
suggests that it plays a role primarily in the PrE state, as it is highly upregulated after four 
days of RA treatment. This expression pattern is concurrent with other inhibitors of WNT 
signalling, such as Dab2. DAB2 inhibits WNT/β-catenin signalling by binding LRP6 and 
promoting its internalization, as well as by interacting with and stabilizing AXIN, 
preventing destruction complex disassembly [60]. Increased levels of Dab2 and Dkk1 
induced by RA in F9 cells would suggest that canonical WNT/β-catenin signalling is 
inhibited in PrE cells at more than one level of the WNT pathway. This blockade in 
canonical WNT/β-catenin signalling has been demonstrated in F9 cells induced to 
differentiate into visceral endoderm (VE). These cells are not responsive to WNTs, and it 
was proposed that a blockade to WNT signalling is necessary in order for F9 cells to 
differentiate into VE, and that WNT signalling inhibits RA-induced differentiation [42]. 
The authors identify Dkk1 as an inhibitor upregulated by F9 cells induced to differentiate 
into VE, but did not observe the effect of ectopic expression of Dkk1 on differentiation 
[42]. In the current study, the data from the Dkk1 overexpression and conditioned 
medium experiments indicating that DKK1 can attenuate differentiation into PrE supports 
the notion that the canonical WNT/-catenin pathway is necessary for this event to occur.  
Thus, differences in the role of the WNT pathway in differentiation may be due to 
differences in activation of cellular pathways associated with VE compared to PrE. 
 Dkk1 is reportedly regulated by the -catenin/TCF/LEF transcriptional complex 
in several cell lines, and there are four TCF/LEF DNA binding motifs located within the 
human and mouse Dkk1 promoter [14]. As Wnt6 is upregulated by GATA6 and FOXA2 
during RA-induced differentiation [51], it was predicted that Dkk1 would be upregulated 
downstream of Wnt6. Dkk1 expression was strongly induced by RA-treatment, and 
furthermore overexpression of Wnt6 induced Dkk1 expression, albeit to a much lesser 
extent than RA. This upregulation of Dkk1 by Wnt6 overexpression supports the notion 
that Dkk1 is regulated by TCF/LEF in F9 cells. However, the significant upregulation of 
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Dkk1 by RA treatment brought into question the possibility of direct Dkk1 regulation by 
the RA pathway. In silico analysis of the Dkk1 promoter revealed the presence of a 
conserved retinoic acid response element (RARE), consisting of a direct repeat of the 
AGGTCA sequence separated by 9bp [61]. The conserved RARE motif is typically 
spaced 1, 2, or 5bp apart, however, other arrangements have been reported in the 
literature [61]. Thus, it seems likely that the Dkk1 gene is regulated by both the RA and 
-catenin signalling pathway, and therefore participates in negative feedback regulation 
of canonical WNT/-catenin signalling in F9 cells. Further analysis using ChIP assays 
would be required to confirm if one or both of the pathways are involved in negative 
feedback of the WNT pathway by DKK1. Nevertheless, there is precedence for this in the 
literature [14].  
 Thus, in our model of F9 cell differentiation, expression of Dkk1 in PrE cells 
would inhibit WNT6 from binding to LRP5/6, but WNT6 can still bind FZD receptors 
present on the plasma membrane. This would reduce canonical WNT/-catenin pathway 
output or inhibit it entirely, preventing -catenin from stabilizing and translocating to the 
nucleus to stop the activation of TCF/LEF target genes that was necessary for PrE 
differentiation. Thus, WNT6-FZD-LRP complex formation in the presence of DKK1 
would be minimal or non-existent, while association of WNT6 with FZD and non-
canonical WNT receptors, such as ROR2, would still be possible. With this in mind, the 
apparent reduction in canonical signalling due to interference with WNT6-LRP 
interactions at the cell surface may place F9 cells in a situation where WNT6 is now able 
to activate non-canonical PCP signalling. Indeed, PCP signalling is reported as necessary 
for oriented migration of PE cells through DAAM1/RHO/ROCK signalling. Treatment of 
F9 cells with SFRP perturbs the actin cytoskeleton and causes a disorganized pattern of 
PE cell migration, and -catenin was found to play no role in this process [28]. Thus, it 
seems that WNT signalling is active in PE cells, but canonical WNT signalling is blocked 
after RA treatment, and this blockade may facilitate the activation of the non-canonical 
pathway due to changes in receptor availability on the plasma membrane. Yamamoto et 
al. (2008) speculate that -catenin signalling is simultaneously inhibited while non-
canonical PCP signalling is activated due to the enhancement of WNT-FZD-ROR2 
complexes at the expense of WNT-FZD-LRP6 complexes, and this is mediated by the 
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collagen triple helix repeat-containing protein 1 (CTHRC1) [14]. Mikels and Nusse 
(2006) also found that WNT-5A can act on the canonical and non-canonical WNT 
pathways, and this depended on the presence of the LRP5/6 co-receptor [60]. Thus, it is 
tempting to speculate that F9 cells also utilize a similar mechanism that involves DKK1 
and other inhibitors to help mediate a switch from canonical WNT/-catenin signalling to 
non-canonical PCP signalling in order to facilitate the outgrowth and oriented migration 
of PE cells, thus completing the transition from PrE to PE. This phenomenon is worthy of 
investigation as it could help further the understanding of how WNTs activate specific 
downstream signalling pathways. 
 Finally, the detection of a signal at approximately 39 kD in conditioned medium 
collected from HEK-293 cells transfected with MYC-DKK1 was evidence for the 
presence of the MYC-DKK1 protein in the medium. However, the bands produced in the 
immunoblot assay were smeared and distorted and might not be reliable proof of the 
presence of the MYC-DKK1 protein in the medium. Rather, they might represent some 
artifact of the protein concentration process or the immunoblot assay. Other assays 
should be used in future conditioned medium studies to demonstrate the presence of the 
ectopically expressed protein such as an enzyme-linked immunosorbent assay (ELISA) 
which could be used to detect the recombinant protein and determine its concentration in 
the medium. It is also important to consider the fact that conditioned medium contains 
many factors in addition to the expressed protein of interest, and it is possible that another 
protein was responsible for the decrease in the TROMA-1 signal (Fig 3.8B, C). However, 
as the control conditioned medium did not inhibit the ability of RA to differentiate cells, 
this is likely not the case. 
 Finally, the necessity of the canonical WNT/β-catenin pathway in PrE 
differentiation has been demonstrated using a dominant-negative mutant of TCF4 [13].  
Expression of this dominant-negative construct in F9 cells blocked the ability of RA to 
induce markers of PrE. My study provides additional support for the necessity of the 
canonical WNT/β-catenin pathway as it demonstrates that inhibition of the WNT 
pathway at the plasma membrane using DKK1 impedes the ability of RA to induce PrE. 
This study provides further evidence for the necessity of the canonical WNT/-catenin 
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pathway in the differentiation of F9 cells into PrE, and highlights the importance of an 
inhibitor of a cell signalling pathway to allow for continued differentiation into a 
different cell type. 
4.5 Conclusion 
 The differentiation of naïve F9 cells into PrE is a highly regulated event that 
requires the presence of canonical WNT/β-catenin signalling. The goal of this study was 
to determine the role of FZD receptors, specifically FZD7, in the differentiation of F9 
cells into PrE. It was hypothesized that FZD7 binds WNT6 during F9 cell differentiation, 
but this was not supported by the data. Many Fzd receptors are expressed in F9 cells and 
in some cases their expression changes in response to RA. FZD7 can potentially serve as 
a receptor for WNT6 as its overexpression induces canonical WNT signalling. However, 
it is not likely the sole FZD receptor for WNT6 in this model system as FZD receptors 
exhibit functional redundancy and the extent of the knockdown of Fzd7 did not have a 
detrimental effect on differentiation. Differentiation into PrE is attenuated when the 
canonical WNT antagonist DKK1 is expressed in the undifferentiated state. This inhibitor 
is expressed endogenously by F9 cells, and is likely involved in a negative feedback loop 
that tightly regulates the canonical WNT signalling pathway once cells reach the PrE 
state. Taken together, these results help to explain the dynamics and the role of the WNT 
signalling pathway in mammalian extraembryonic endoderm differentiation. Given the 
role of the WNT pathway in cancer, it may also provide a better understanding of how 
metastatic cancers utilize the WNT pathway to undergo EMTs and migrate to secondary 
sites. The role of negative feedback loops in processes such as differentiation is 
exemplified by the expression and regulation of Dkk1 in this system. That its ectopic 
expression perturbs the differentiation into PrE highlights the importance of modulating 
the canonical WNT/-catenin signalling pathway at the correct time throughout 
differentiation.  
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Appendices 
Appendix 1- Primer sequences and annealing temperatures 
 Forward Reverse Annealing 
Temp. (Ta) 
Fzd1 5’-CAAGGTTTACGGGCTCATGT-3’ 5’-TGAACAGCCGGACAGGAAAA-
3’ 
60.5  
Fzd2 5’-CCGACGGCTCTATGTTCTTC-3’ 5’-TAGCAGCCGGACAGAAAGAT-
3’ 
62  
Fzd3 5’-TGGGTTGGAAGCAAAAAGAC-
3’ 
5’-CCTGCTTTGCTTCTTTGGTC-3’ 
54  
Fzd4 5’-GCCAATGTGCACAGAGAAGA-
3’ 
5’-AGGTGGTGGAGATGAAGCAG-
3’ 
56  
Fzd5 5’-CTGTGGTCTGTGCTGTGCTT-3’ 5’-GGCCATGCCAAAGAAATAGA-
3’ 
55  
Fzd6 5’-TCTGTGCCTCTGCGTATTTG-3’ 5’-TCTCCCAGGTGATCCTGTTC-3’ 
57.5  
Fzd7 5’-GCTTCCTAGGTGAGCGTGAC-3’ 5’-AACCCGACAGGAAGATGATG-
3’ 
55  
Fzd8 5’-TTACATGCCCAACCAGTTCA-3' 5’-CGGTTGTAGTCCATGCACAG-
3’ 
55  
Fzd9 5’-AGTTTCCTCCTGACCGGTTT-3’ 5’-TTTTCGGTAGCACAGGCTCT-3’ 
55  
Fzd10  5’-AGATTCCCATGTGCAAGGAC-
3’ 
 5’-AGTTGGGGTCGTTCTTGTTG-
3’ 
58 
Gata6 5’-CTCTGCACGCTTTCCCTACT-3’ 5’-GTAGGTCGGGTGATGGTGAT-
3’ 
58  
Wnt6 5’-GCGGTAGAGCTCTCAGGATG-
3’ 
5’-AAAGCCCATGGCACTTACAC-
3’ 
57  
Dkk1  5’-
TGAAGATGAGGAGTGCGGCTC-3’ 
5’-GGCTGTGGTCAGAGGGCATG-
3’ 
61.9  
Dab2 5’-GGAGCATGTAGACCATGATG- 5’-AAAGGATTTCCGAAAGGGCT-
61.4 
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3’ 3’ 
L14 5’-
GGGAGAGGTGGCCTCGGACGC-3’ 
5’-GGCTGGCTTCACTCAAAGGCC-
3’ 
60 
 
Appendix 2- Fold change Fzd mRNA expression in response to RA (relative to DMSO-
treated cells) 
 
 
 
 
  
Frizzled gene Fold Change Fzd mRNA 
expression (2
-ΔΔCt
)  
Fzd1 9.82 
Fzd2 2.5 
Fzd4 4.86 
Fzd5 0.83 
Fzd6 1.54 
Fzd7 1.26 
Fzd8 3.69 
Fzd10 0.61 
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Appendix 3- Fold change TCF/LEF luciferase activity relative to DMSO 
 
 
 
 
 
 
 
 
Appendix 4- Fold change Dkk1 mRNA expression in response to RA or Wnt6 (relative to 
DMSO-treated or empty vector transfected cells, respectively)  
 
Treatment Fold Change Dkk1 mRNA Expression (2
-ΔΔCt
) 
DMSO 1.00 
RA Day 1 3.70 
RA Day 2 27.15 
RA Day 3 118.70 
RA Day 4 611.46 
 
 
Treatment Fold change RLU (Relative Light Units) 
DMSO 1.00 
RA 4.32 
pcDNA3.1 1.05 
Fzd7 3.06 
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Treatment Fold Change Dkk1 mRNA Expression (2
-ΔΔCt
) 
pcDNA3.1 1.00 
Wnt6 2.92 
 
Appendix 5- Fold change Dab2 mRNA expression in response to transfection with 
empty vector or MYC-DKK1 and treatment with DMSO or RA (relative to pcDNA3.1 
+DMSO) 
 
Treatment Fold Change Dab2 mRNA Expression (2
-ΔΔCt
) 
pcDNA3.1 +DMSO 1.00 
pcDNA3.1 +RA 141.40 
MYC-DKK1 +RA 118.35 
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